Drug Approval | April 18, 2022
Lupin receives tentative approval from USFDA for Tenofovir Alafenamide Tablets
This product will be manufactured at Lupin’s Nagpur facility in India
This product will be manufactured at Lupin’s Nagpur facility in India
The drug will be manufactured at the group's injectables manufacturing facility at Jarod, Gujarat
The product will be manufactured at Lupin’s facility in Goa, India
This product is indicated for the short-term treatment of a breathing problem (apnea) in premature infants
The expansion positions Cambrex with the largest and most advanced API facility in the United States
The DRX-Compass helps navigate and accelerate towards superb performance with a solution that grows with its customers
The funding round is led by Kalaari Capital. Aflac Ventures, Digital Horizon, Stride Ventures, and existing investors also participated in the round
It supports advanced research and helps scientists accelerate potential cures, drug discoveries and diagnostics research
Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation
Although PCM has advanced substantially in recent years, most of the valuable technical information resides with private companies and academic publications across multiple platforms
Subscribe To Our Newsletter & Stay Updated
